Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Protamine Dose Reduction on Platelet Aggregation After Extracorporeal Circulation for Minimally Invasive Aortic Valve Replacement Surgery

NCT06254404 is registered in ClinicalTrials.gov with University of Liege as lead sponsor.

NCT NCT06254404
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06254404 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Protamine Dose Reduction on Platelet Aggregation After Extracorporeal Circulation for Minimally Invasive Aortic Valve Replacement Surgery
Lead sponsor
University of Liege
Phase
Not applicable
Overall status
Unknown status
Start date
March 15, 2024
Completion date
October 1, 2024
Enrollment
50 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

protamine adverse reaction, protamine dose